{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-002198","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.999567+00:00","generated_at":"2026-05-28T04:29:10.676713+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cyclacel corrects board appointment error in Securities Purchase Agreement with David Lazar","bullets":["Addendum corrects inadvertent error: Mr. Lazar was not appointed as Board member or Chairman, only has right to appoint one director.","David Natan appointed as designee of Lazar and chairman of audit committee.","Amendment restates Section 2.3(a)(v) to reflect correct intent regarding board appointment and resolutions.","All other terms of the Purchase Agreement remain unchanged and in full force and effect."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-002198","json":"https://secwatch.observer/filing/0001104659-25-002198.json","markdown":"https://secwatch.observer/filing/0001104659-25-002198.md","text":"https://secwatch.observer/filing/0001104659-25-002198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925002198/0001104659-25-002198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925002198/tm252869d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:29:10.676713+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}